Literature DB >> 3205721

An upstream enhancer and a negative element in the 5' flanking region of the human urokinase plasminogen activator gene.

P Verde1, S Boast, A Franzè, F Robbiati, F Blasi.   

Abstract

The 5' flanking region of the human urokinase (uPA) gene has been fused to the reporter chloramphenicol acetyl transferase (CAT) gene and its activity assayed by transfection in two human cell lines. Progressive deletions of the uPA regulatory region from the 5' end maintain a high level of expression provided at least 1870 (in A1251 cells) or 1963 (in HFS10 cells) nucleotides of the 5' flanking region are retained. A DNA fragment from -2350 to -1824 has enhancer properties, stimulating transcription of an enhancerless SV40 early promoter independently of orientation and distance. Internal deletions that still retain the enhancer element reveal the presence of negative cis-acting sequences between -1824 and -1572. Their removal, in fact, increases uPA transcriptional activity. Differences of expression of the uPA-CAT fusion genes in the two cell lines are also observed, indicating the presence of cell-specific cis-acting sequences.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3205721      PMCID: PMC338934          DOI: 10.1093/nar/16.22.10699

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  49 in total

Review 1.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

2.  The human beta-interferon gene enhancer is under negative control.

Authors:  S Goodbourn; H Burstein; T Maniatis
Journal:  Cell       Date:  1986-05-23       Impact factor: 41.582

3.  Dideoxy sequencing method using denatured plasmid templates.

Authors:  M Hattori; Y Sakaki
Journal:  Anal Biochem       Date:  1986-02-01       Impact factor: 3.365

4.  Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements.

Authors:  T Edlund; M D Walker; P J Barr; W J Rutter
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

5.  Characterization of a "silencer" in yeast: a DNA sequence with properties opposite to those of a transcriptional enhancer.

Authors:  A H Brand; L Breeden; J Abraham; R Sternglanz; K Nasmyth
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

6.  Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus.

Authors:  L A Laimins; P Gruss; R Pozzatti; G Khoury
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

7.  The human urokinase-plasminogen activator gene and its promoter.

Authors:  A Riccio; G Grimaldi; P Verde; G Sebastio; S Boast; F Blasi
Journal:  Nucleic Acids Res       Date:  1985-04-25       Impact factor: 16.971

8.  Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

Authors:  K A Jones; J T Kadonaga; P A Luciw; R Tjian
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

9.  Tumor promoter PMA stimulates the synthesis and secretion of mouse pro-urokinase in MSV-transformed 3T3 cells: this is mediated by an increase in urokinase mRNA content.

Authors:  D Belin; F Godeau; J D Vassalli
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

10.  Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.

Authors:  M P Stoppelli; P Verde; G Grimaldi; E K Locatelli; F Blasi
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

View more
  23 in total

Review 1.  Pathways of Egr-1-mediated gene transcription in vascular biology.

Authors:  E S Silverman; T Collins
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

Review 2.  Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis.

Authors:  Florian Blaschke; Dennis Bruemmer; Ronald E Law
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression.

Authors:  Narasimhaswamy S Belaguli; Muhammad Aftab; Mohammed Rigi; Mao Zhang; Daniel Albo; David H Berger
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

4.  Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate.

Authors:  G Cirillo; L Casalino; D Vallone; A Caracciolo; D De Cesare; P Verde
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

5.  Glycodelin-A protein interacts with Siglec-6 protein to suppress trophoblast invasiveness by down-regulating extracellular signal-regulated kinase (ERK)/c-Jun signaling pathway.

Authors:  Kevin K W Lam; Philip C N Chiu; Cheuk-Lun Lee; Ronald T K Pang; Carmen O N Leung; Hannu Koistinen; Markku Seppala; Pak-Chung Ho; William S B Yeung
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

6.  Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester.

Authors:  P Rørth; C Nerlov; F Blasi; M Johnsen
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

7.  Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5' non-coding sequences that are conserved between mouse and pig.

Authors:  A I Cassady; K J Stacey; K A Nimmo; K M Murphy; D von der Ahe; D Pearson; F M Botteri; Y Nagamine; D A Hume
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

Review 8.  Invasion and metastasis.

Authors:  D Boyd
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

9.  Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1.

Authors:  Markus Diefenbacher; Sylwia Sekula; Christine Heilbock; Jana V Maier; Margarethe Litfin; Hans van Dam; Marc Castellazzi; Peter Herrlich; Olivier Kassel
Journal:  Mol Endocrinol       Date:  2008-06-05

10.  Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell line.

Authors:  W Hollas; E Soravia; A Mazar; J Henkin; F Blasi; D Boyd
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.